1-9 of 9
Ravinder Dhawan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Characteristics Of Patients Included In The Myelofibrosis Real-World Practice-Based Network Research (ENRiCH) Data Platform

Gregory Hess, Eileen Fonseca, Andrew Lee, Hongwei Wang, Ravinder Dhawan, Stephen F Thompson, Sheikh Usman Iqbal, Sean Redmond
Journal: Blood
Blood (2013) 122 (21): 1580.
https://doi.org/10.1182/blood.V122.21.1580.1580
Published: 2013
Journal Articles

Efficacy of Bortezomib Plus Dexamethasone Versus Bortezomib Monotherapy In Patients with Relapsed/Refractory Multiple Myeloma: An Interim Report from an International Electronic Observational Study

Meletios A. Dimopoulos, Hadewijch M De Samblanx, MD, Maria G Roussou, Konstantinos Zervas, Eirini Katodritou, Deniz Sargin, MD, Cyrille Hulin, MD, Lucia Ahlberg, MD, Javier De La Rubia, Rita Ganguly, PhD, Joris K Diels, MSc, Helgi van de Velde, MD, PhD, Ravinder Dhawan, PhD, Michael D Spencer, MSc, Michel Delforge, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3027.
https://doi.org/10.1182/blood.V116.21.3027.3027
Published: 2010
Journal Articles

The Cost-Effectiveness of Bortezomib Plus Melphalan and Prednisone Versus Lenalidomide Plus Melphalan and Prednisone with Continuous Lenalidomide Maintenance Treatment for the Initial Treatment of Multiple Myeloma In the United States

Si-Tien Wang, MS, Hui Huang, PhD, MBA, Abbie Ba-Mancini, BS, MBA, Hongliang Shi, MS, Kristina Chen, MS, Caroline Korves, ScD, Ravinder Dhawan, PhD, Andrew Cakana, FRCPath, MD, Helgi van de Velde, Dixie-Lee W. Esseltine, MD, FRCPC, Mei S. Duh, ScD, MPH
Journal: Blood
Blood (2010) 116 (21): 2563.
https://doi.org/10.1182/blood.V116.21.2563.2563
Published: 2010
Journal Articles

International Observational Study On Bortezomib (VELCADE) in Relapsed Multiple Myeloma: Preliminary Efficacy and Quality of Life (QoL) Results From the Belgian Population.

Michel Delforge, MD, PhD, Hadewijch De Samblanx, Hilde Demuynck, Greet Bries, Philippe Mineur, Nathalie Meuleman, Fritz Offner, Chantal Doyen, Walter Feremans, Ann Van de Velde, Christophe Ravoet, Isabelle Vande Broek, Jan Van Droogenbroeck, Gabry Kuijten-Celzo, Joris Diels, Rita Ganguly, Ravinder Dhawan
Journal: Blood
Blood (2009) 114 (22): 4523.
https://doi.org/10.1182/blood.V114.22.4523.4523
Published: 2009
Journal Articles

The Cost-Effectiveness of Bortezomib for the Initial Treatment of Multiple Myeloma in the United States.

Si-Tien Wang, Hui Huang, Hongliang Shi, Mei Sheng Duh, Kristina Chen, Eva Chang, Caroline Korves, Ravinder Dhawan, Andrew Cakana, Helgi van de Velde, Dixie-Lee Esseltine, Louis Garrison
Journal: Blood
Blood (2009) 114 (22): 1379.
https://doi.org/10.1182/blood.V114.22.1379.1379
Published: 2009
Journal Articles

Sustained Health-Related Quality of Life (HRQoL) Improvement in Newly Diagnosed Multiple Myeloma Patients Treated with Bortezomib/Melphalan/Prednisone Versus Melphalan/Prednisone: Results From the VISTA Trial.

Ravinder Dhawan, Don Robinson Jr., Juliette Meunier, Antoine Regnault, Kathleen Rosa, Andrew Z Cakana, Helgi van de Velde, Paul G Richardson, Jesús F San Miguel
Journal: Blood
Blood (2009) 114 (22): 1881.
https://doi.org/10.1182/blood.V114.22.1881.1881
Published: 2009
Journal Articles

Characterization of Patients with Multiple Myeloma Achieving Complete Response to Bortezomib: An Interim Report From An International Electronic Observational Study.

Michel Delforge, MD, PhD, Hadewijch De Samblanx, Maria Roussou, Konstantinos Zervas, Eirini Katodritou, Kudrat M Abdulkadyrov, Deniz Sargin, Cyrille Hulin, Lucia Ahlberg, Javier de la Rubia, Rita Ganguly, Joris Diels, Ravinder Dhawan, Meletios A. Dimopoulos
Journal: Blood
Blood (2009) 114 (22): 4938.
https://doi.org/10.1182/blood.V114.22.4938.4938
Published: 2009
Journal Articles

Response to Bortezomib Therapy for Multiple Myeloma (MM) in Actual Clinical Practice: Preliminary Effectiveness Findings of an International Observational Study.

Michel Delforge, MD, PhD, Eirini Katodritou, MD, PhD, Konstantinos Zervas, MD, PhD, Deniz Sargin, MD, Cyrille Hulin, MD, Mats Linderholm, MD, PhD, Evgenia Verrou, MD, Vicki Poon, MPH, Ravinder Dhawan, PhD
Journal: Blood
Blood (2007) 110 (11): 4837.
https://doi.org/10.1182/blood.V110.11.4837.4837
Published: 2007
Journal Articles

Economic Evaluation of Bortezomib (VELCADE) for Relapsed and Refractory Multiple Myeloma.

Adrian Bagust, Alan R. Haycox, Angela Boland, Patrick Chu, Gareth J. Morgan, Ruben E. Mujica Mota, Dominique Dubois, Ravinder Dhawan
Journal: Blood
Blood (2004) 104 (11): 268.
https://doi.org/10.1182/blood.V104.11.268.268
Published: 2004